Algestone
| Algestone | |
|---|---|
| Algestone.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 595-77-7 |
| PubChem | 68943 |
| DrugBank | |
| ChemSpider | 62156 |
| KEGG | D02899 |
Algestone, also known as 16α,17α-dihydroxyprogesterone, is a synthetic progestin of the 17α-hydroxyprogesterone group. It is a derivative of progesterone and is used in hormonal contraception and hormone replacement therapy.
Chemical Structure[edit]
Algestone is characterized by its chemical structure as a 17α-hydroxyprogesterone derivative. The presence of hydroxyl groups at the 16α and 17α positions distinguishes it from other progestins. This modification enhances its progestogenic activity and influences its pharmacokinetic properties.
Pharmacology[edit]
Algestone acts primarily as a progestogen, binding to the progesterone receptor and exerting effects similar to those of natural progesterone. It is involved in the regulation of the menstrual cycle, maintenance of pregnancy, and development of the endometrium.
Mechanism of Action[edit]
The mechanism of action of algestone involves its interaction with the progesterone receptor, leading to changes in gene expression that result in the suppression of ovulation, thickening of the cervical mucus, and alteration of the endometrial lining, making it less suitable for implantation.
Clinical Use[edit]
Algestone is used in various hormonal therapies, including contraceptive formulations and hormone replacement therapy for menopausal symptoms. Its use is often combined with estrogens to enhance efficacy and reduce side effects.
Side Effects[edit]
Common side effects of algestone include nausea, headache, breast tenderness, and mood changes. Long-term use may be associated with an increased risk of thromboembolism and breast cancer.
Synthesis[edit]
The synthesis of algestone involves the chemical modification of progesterone, introducing hydroxyl groups at specific positions to enhance its progestogenic activity. This process requires precise control of reaction conditions to achieve the desired stereochemistry.
Related Compounds[edit]
Algestone is related to other synthetic progestins such as medroxyprogesterone acetate and norethisterone, which are also used in hormonal therapies. These compounds share a common mechanism of action but differ in their pharmacokinetic profiles and side effect profiles.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
